Analyzing The Price Action In Nurix Therapeutics Stock Today

Nurix Therapeutics's Stock Price And Volume Action Nurix Therapeutics's (NASDAQ:NRIX) stock has been rising Wednesday, up 13.87% to a price of $30.02. The stock's current volume for the day is 150.40 thousand, which is approximately 22.88% of its previous 30-day average volume of 657.40 thousand.

Nurix Therapeutics's Stock Price And Volume Action

Nurix Therapeutics's (NASDAQ:NRIX) stock has been rising Wednesday, up 13.87% to a price of $30.02. The stock's current volume for the day is 150.40 thousand, which is approximately 22.88% of its previous 30-day average volume of 657.40 thousand.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Nurix Therapeutics shares are trading higher after Berenberg initiated coverage on the stock with a Buy rating.

Perspective On Recent Price Action

The 50-day moving average price of Nurix Therapeutics's stock was $35.71 when this article was published. The stock reached a high of $52.38 and a low of $15.21 in the past 52 weeks.

If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.

Total
0
Shares
Related Posts
Read More

DiaMedica Therapeutics Announces Interim Results From Phase 2 REDUX Study In CKD; Says Results ‘Affirm Biological Activity, Safety and Tolerability of DM199’ And Indicate ‘Statistically and Clinically Significant Reduction in UACR’

Results Affirm Biological Activity, Safety and Tolerability of DM199 Consistent with Porcine KLK1 Product in Asia Early Data Indicate Statistically and Clinically Significant Reduction in UACR seen in IgA Nephropathy

DMAC